Wenli Dong, M.S.
Senior Statistical Analyst
- M.S. in Biomathematics and Biostatistics, The University of Texas Graduate School of Biomedical Sciences, Houston, TX
- M.S. in Computer Science, University of Houston, Houston,TX
Areas of Interest
- Clinical trial design and analysis
- Cost-effectiveness analysis of cancer prevention and treatment
- Statistical computing and simulation
- Data management for clinical research
Parker PA, Peterson SK, Bedrosian I, Crosby MA, Shen Y , Black DM, Babiera G, Kuerer HM, Ying J, Dong W, Cantor S, Brewster AM. Prospective study of surgical decision-making processes for contralateral prophylactic mastectomy in women with breast cancer. Ann Surg 2015; Mar 27 Epub.
Lewis CM, Chronowski GM, Dong W, Gunn B, Rosenthal D, Weber R. Analysis of charges associated with definitive nonsurgical therapy for early-stage lateralized tonsil cancer. Ann Surg Oncol 2015; 22(8):2755-2760.
Rathi N, Tanner AR, Dinh A, Dong W, Feng L, Ensor J, Wallace S, Haque S, Rondon G, Price K, Popat U, Nates J. Low, medium and high dose steroids with or without aminocaproic acid in adult hematopoietic stem cell transplant patients with diffuse alveolar hemorrhage . Bone Marrow Transplant 2015; 50(3):420-426.
Ahern C, Shih Y, Dong W, Parmigiani G, Shen Y. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. British Journal of Cancer 2014; 111:1542–1551.
Shih Y, Xu Y, Dong W, Smieliauskas F, Giordano S, Shen Y. First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer. Breast Cancer Res Treat 2014; 144(2):417-425.
Deshmukh A, Cantor SB, Crosby MA, Dong W, Shen Y, Bedrosian I, Peterson SK, Parker PA, Brewster AM. Cost of contralateral prophylactic mastectomy. Ann Surg Oncol 2014; 21(9):2823-2830.
Middleton LP, Sneige N, Coyne R, Shen Y, Dong W, Dempsey P, Bevers TB. Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med 2014; 3(3):492-499.
Thomas L, Lai SY, Dong W, Feng L, Dadu R, Regone RM, Cabanillas ME. Sorafenib in metastatic thyroid cancer: a systematic review. Oncologist 2014; 19(3):251-258.
Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Annals of Oncology 2013; 24(10):2506-14
Westin JR, Thompson MA, Cataldo VD, Fayad LE, Fowler N, Fanale MA, Neelapu S, Samaniego F, Romaguera J, Shah J, McLaughlin P, Pro B, Kwak LW, Sanjorjo P, Murphy WA, Jimenez C, Toth B, Dong W, Hagemeister FB. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. Clinical Lymphoma Myeloma Leukemia 2013; 13(2):99-105.
Soliz JM, Gebhardt R, Feng L, Dong W, Reich M, Curley S. Comparing epidural analgesia and ON-Q infiltrating catheters for pain Management after hepatic resection. Open Journal of Anesthesiology 2013; 3:3-7.
Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, Crosby M, Shen Y. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer 2012; 118(22): 5637-5643.
Sun L, Zhang L, Qian J, Yang J, Yi Q, Dong W, Wang M. Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo. Leukemia Research 2012; 36(3): 363-368.
Luo C, Zuñiga J, Edison E, Palla S, Dong W, Parker-Thornburg J. Superovulation strategies for six commonly used mouse strains. Journal of the American Association for Laboratory Animal Science 2011; 50(4): 471-478.
Crosby MA, Dong W, Feng L, Kronowitz SJ. Effect of intraoperative saline fill volume on perioperative outcomes in tissue expander breast reconstruction. Plastic and Reconstructive Surgery 2011; 127(3): 1065-1072.
Richards KL, Zhang B, Sun M, Dong W, Churchill J, Bachinski LL, Wilson CD, Baggerly KA, Yin G, Hayes DN, Wistuba II, Krahe R. Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer 2011; 117(3): 606-617.
Jacob LM, Dong W, Chang DW. Outcomes of reconstructive surgery in pediatric oncology patients: review of 10-year experience. Annals of Surgical Oncology 2010; 17(10): 2563-2569.
Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA, Corvalan AH, Biswal S, Swisher SG, Bekele BN, Minna JD, Stewart DJ, Wistuba II. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clinical Cancer Research 2010; 16(14): 3743-3753.
Yuan P, Kadara H, Behrens C, Tang X, Woods D, Solis LM, Huang J, Spinola M, Dong W, Yin G, Fujimoto J, Kim E, Xie Y, Girard L, Moran C, Hong WK, Minna JD, Wistuba II. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One 2010; 5(2): e9112.
Garvey PB, Rhines LD, Dong W, Chang DW. Immediate soft-tissue reconstruction for complex defects of the spine following surgery for spinal neoplasms. Plastic and Reconstructive Surgery 2010; 125(5): 1460-1466.
Brannan JM, Sen B, Saigal B, Prudkin L, Behrens C, Solis L, Dong W, Bekele BN, Wistuba I, Johnson FM. EphA2 in the early pathogenesis and progression of non-small cell lung cancer. Cancer Prevention Research 2009; 2(12): 1039-1049.
Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery 2009; 146(6): 1116-1122.
Brannan JM, Dong W, Prudkin L, Behrens C, Lotan R, Bekele BN, Wistuba I, Johnson FM. Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer. Clinical Cancer Research 2009; 15(13): 4423-4430.
Shen Y, Dong W, Feig BW, Ravdin P, Theriault RL, Giordano SH. Patterns of treatment for early-stage breast cancers in MD Anderson Cancer Center from 1997 to 2004. Cancer 2009; 115(10): 2041-2051.
Dong W, Berry DA, Bevers TB, Kau SW, Hsu L, Theriault RL, Shen Y. Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas MD Anderson Cancer Center experience. Cancer Epidemiology, Biomarkers & Prevention 2008; 17(5): 1096-1103.
Shen Y, Dong W, Esteva FJ, Kau S, Theriault RL, Bevers T. Are there racial differences in breast cancer treatments and clinical outcomes for women treated at MD Anderson Cancer Center? Breast Cancer Research and Treatment 2007; 102(3): 347-356.
Some Abstracts and Presentations
Fujii T, Kogawa T, Dong W, Moulder S, Litton JK, Tripathy D, Lim B, Shen Y, Ueno NT. Association between quantitative values of estrogen receptor expression level and pathological complete response in human epidermal growth factor 2-negative breast cancer; Should the clinical definition of triple-negative breast cancer be redefined? San Antonio Breast Cancer Symposium, 2015.
Manasanch EE, Claussen CM, Dong W, Shah J, Lee H, Thomas S, Reed VK, Dabaja BS, Milgrom S, Pinnix CC, Orlowski R, Feng L, Weber D. Clinical characteristics, outcomes and predictors of progression to multiple myeloma in 61 patients with solitary plasmacytoma. International Myeloma Workshop, 2015.
Zheng G, Lewis CM, Dong W, Huang N, Rozner M. The influences of head and neck radiation therapy on intraoperative hemodynamic responses: A 10-year data review. American Society of Anesthesiologist, 2014.
Fan Z, Lin P, Moon BS, Satcher RL, Bird JE, Dong W, Lewis V. Radiation and chemotherapy for non-metastatic (AJCC StageⅡB-Ⅲ) extraosseous osteosarcoma. Musculoskeletal Tumor Society, 2013.
Jiralerspong S, Kim ES, Dong W, Feng L, Gonzalez-Angulo A, Hortobagyi G, Giordano S. Diabetes, obesity, and survival outcomes in early breast cancer. ASCO 2010
Yuan P, Kadara H, Behrens C, Tang X, Woods D, Solis LM, Huang J, Spinola M, Dong W, Yin G, Fujimoto J, Kim E, Xie Y, Girard L, Moran C, Hong WK, Minna JD, Wistuba II. Sex determining region Y-box 2 is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. AACR 2010
Yuan P, Behrens C, Huang J, Spinola M, Prudkin L, Dong W, Yin G, Moran C, Kim E, Zhou B, Minna J, Wistuba I. Expression of stem cell markers in non-small cell lung carcinoma (NSCLC) and correlation with clinico-pathologic features. IASLC 2009
Holsinger C, Dong W, Bekele BN, Weber RS, Kies MS, Glisson BS. Clinicopathologic predictors of distant metastasis in head and neck cancer. ASCO 2009
Li X, Tang X, Behrens C, Dong W, Ozburn N, Woods D, Yin G, Hong W, Moran C, Wistuba I. STAT1 protein frequently overexpressed in non-small cell lung carcinoma. AACR 2008
Brannan JM, Ozburn NC, Prudkin ML, Dong W, Bekele BN, Wistuba II, Johnson FM. Knockdown of the tyrosine kinase EphA2 leads to decreased migration and colony size in non-small cell lung cancer (NSCLC) cell lines. AACR 2008
Dong W, Berry DA, Bevers TB, Kau S, Hsu L, Theriault RL, Shen Y. Prognostic role of detection method in breast cancer: MD Anderson Cancer Center experience. AACR 2007
Updated September 29, 2015